Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
Guest Alerts | Access Rights | My Account | Sign In
|
|
This Special Advertisising Section is brought to you by AAAS OPMS
The companies in this article were selected at random. Their inclusion in this article does not indicate endorsement by either AAAS or Science, nor is it meant to imply that their products or services are superior to those of other companies. science.labvelocity.com. The 96-well microplate fulfilled many of those desires. Multiwell plates also triggered advances in laboratory automation and miniaturization. As the following experts reveal, handling fluids more quickly and efficiently plays a fundamental role in pushing basic and applied research to ever faster speeds.
Lowering the Levels Moreover, different experiments demand wells of different shapes and made of different materials or coated with different treatments. Companies like Corning, Nalge Nunc, and Greiner Bio-One offer a range of plasticware products. For example, Corning offers microwell plates with modified polystyrene surfaces. McFarland says, “Some cells like to grow on a surface, and others prefer growing in suspension. Some assays—such as ones involving microscope imaging—need cells to stay in place.” Corning also offers its CellBIND surfaces for cell based assays. McFarland says that this treatment encourages many cell lines to attach faster and proliferate more quickly. He adds, “This is also very useful in any situation where a scientist needs a way to get more cells, such as producing cells for high throughput screening assays or when using cells to produce biotherapeutics.”
Relying on Robotics According to Joerg Pochert, director of the pharma and biotech group at Hamilton, scientists seek increasing reproducibility and process stability. This is why Pochert’s company developed the Microlab STAR liquid-handling work station. Pochert says, “The STAR is something that has not been available so far. There are no syringes, no pumps, and no tubing.” Instead, this system works like automated, hand-held pipettes. Pochert adds, “This technology also allows us to monitor each pipetting step, therefore achieving previously unknown process stability.”
Micro Spots and Micro Flows In microarrays, advances often revolve around more genes on an array or processing arrays more quickly. Stephen Fodor, chairman and chief executive officer of Affymetrix, says, “The GeneChip Mapping 100K Array Set is capable of genotyping over 100,000 SNPs [single nucleotide polymorphisms].” He adds, “Jeffrey Friedman, Markus Stoffel, and Jan Breslow of the Rockefeller University are using this array technology to genotype approximately 200,000 SNPs per individual for the complete adult population of the Micronesian island of Kosrae.” This population is especially interesting because it developed obesity following dietary changes—receiving Western foods—after World War II. Fodor says, “Rockefeller scientists are using genotyping microarrays to identify the exact genetic variations that might explain why only some individuals developed obesity, cardiovascular disease, and diabetes.” Scientists can combine biological assays with microscale plumbing to build what is known as a lab-on-a-chip. Kevin Hrusovsky, president and chief executive officer of Caliper Life Sciences, says, “Our LabChip technology uses miniature volumes of sample to run tests that have multiple advantages over traditional assays—accurate, information-rich data being the most important of these advantages.” The microfluidic chip brings together the target and reagents, separates the analytes or cells of interest, and then the reaction can be detected directly on the chip. Hrusovsky adds, “Our LabChip 3000 Drug Discovery System, which was launched in February 2004, is gaining rapid acceptance as a very proficient way to do drug screening and drug discovery.”
Tracking the Workflow According to Scott Kahn, chief scientific officer at Accelrys, “The most fundamental challenge in lab automation is how to develop a workflow that doesn’t just collect data but acts on it and does necessary analysis on the fly to drive the result to its ultimate destination.” In other words, the analysis software helps a scientist decide how to run an experiment in real time. Accelrys provides several new approaches to automation. Its Accord HTS manages high throughput experiments, Accord Inventory manages libraries of compounds, and Pipeline Pilot links disparate data and creates a processed result. Osman Güner, Accelrys’s executive director of cheminformatics and rational drug design, says, “These tools enable a scientist to make better informed decisions, and there are lots of very expensive decisions in discovery, design, and development of a new product.” The combination of handling smaller samples in higher numbers and keeping track of the process with intelligent tools will change the experiments that scientists and clinicians can do. “To improve human health,” says Fodor of Affymetrix, “we need to shift the paradigm from diagnosing and treating an existing disease, to one in which we predict disease susceptibility, determine individual response to drugs, and focus on earlier detection, more accurate diagnosis, and therapeutic management.” Making more automated laboratories will help scientists push toward this arena of so-called personalized medicine and other achievements in basic research and biotechnology. Mike May (mikemay{at}mindspring.com) is a freelance writer and editor based in Madison, Indiana, U.S.A. Gary Heebner
|
||||||||||||||||||||||||||
Science. ISSN 0036-8075 (print), 1095-9203 (online)